INS and cancer: This revealed that the intervention decreased insulin levels compared to the control group [(SMD = −0.41, CI = (−0.74)–(−0.08), Z = 2.44, I2 = 45%, p = 0.01; Figure 6], with no differences between cancer types (p > 0.05; Figure S9 in Supplement S1, page 23).